P354: Vosoritide as a targeted therapy for FGFR3-related thanatophoric dysplasia

• Benjamin Cocanougher,
• Rose Sharpe,
• Mariele Anneling,
• Brooke Baker,
• Nicole Panosh,
• Dmitriy Niyazov,
• Susan Izatt,
• Jennifer Cohen

Affiliations

Benjamin Cocanougher

Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC

Rose Sharpe

Palliative Care, Division of Hospital Medicine, Duke University, Durham, NC

Mariele Anneling

Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC

Brooke Baker

Department of Pharmacy, Duke University Medical Center, Durham, NC

Nicole Panosh

Department of Pharmacy, Duke University Medical Center, Durham, NC

Dmitriy Niyazov

Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC

Susan Izatt

Division of Neonatology, Department of Pediatrics, Duke University Medical Center, Durham, NC

Jennifer Cohen

Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC